Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/15617
Citations
Scopus Web of ScienceĀ® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAgius, S.en
dc.contributor.authorCorkindale, D.en
dc.contributor.authorDottore, A.en
dc.contributor.authorGilbert, M.en
dc.date.issued2006en
dc.identifier.citationInternational Journal of Technology Intelligence and Planning, 2006; 2(2):117-128en
dc.identifier.issn1740-2832en
dc.identifier.issn1740-2840en
dc.identifier.urihttp://hdl.handle.net/2440/15617-
dc.descriptionPublisher's postprint archived as permitted by publisher.en
dc.description.abstractThe way in which companies, research centres and educational institutions are organised and structured may provide a competitive advantage for commercialisation, in particular if companies are dependent on the deployment of complementary assets and capabilities by third parties. This paper presents the case of the Australian Centre for Plant Functional Genomics (ACPFG), a private agricultural biotechnology (agbiotech) company specialising in early stage Research and Development (R&D) to produce superior adapted cereal varieties, tolerant to abiotic stress conditions such as drought, frost, salt, or mineral toxicity, all of which have a direct and negative impact on plant growth and crop productivity. The organisational structure of the company has been influenced and shaped by Government policy, shareholders expectations and trends in the agbiotech industrial organisation. It has proved attractive to potential alliance partners for collaborative R&D and commercialisation. We present the ACPFG as a new business model to fund basic research and facilitate technology transfer.en
dc.description.statementofresponsibilityStephanie C. Agius, David Corkindale, Antonio G. Dottore, Michael Gilberten
dc.format.extent485297 bytesen
dc.format.mimetypeapplication/pdfen
dc.language.isoenen
dc.publisherInderscience Publishersen
dc.subjecttransaction costs; commercialisation; complementary assets; Australian Centre for Plant Functional Genomics (ACPFG); intellectual property; industry consolidation; technology transfer; licensing; agricultural biotechnology (agbiotech); core competencies; strategic allianceen
dc.titleDeveloping a new business model for enabling research - the case of the ACPFG in Australiaen
dc.typeJournal articleen
dc.identifier.rmid0020073573en
dc.contributor.organisationEntrepreneurship, Commercialisation & Innovation Centreen
dc.identifier.doi10.1504/IJTIP.2006.011303en
dc.identifier.pubid46967-
pubs.library.collectionEntrepreneurship, Commercialisation, and Innovation Centre publicationsen
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
Appears in Collections:Entrepreneurship, Commercialisation, and Innovation Centre publications

Files in This Item:
File Description SizeFormat 
01 Agius.pdfPostprint of journal article473.92 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.